HER-2 유전자를 이용한 폐암 감수성 진단용 마커 및 이를 이용한 폐암 감수성 진단 방법
    1.
    发明公开
    HER-2 유전자를 이용한 폐암 감수성 진단용 마커 및 이를 이용한 폐암 감수성 진단 방법 有权
    使用HER-2基因诊断肺癌易感性的制造商以及使用该方法预测和分析肺癌易感性的方法

    公开(公告)号:KR1020090106430A

    公开(公告)日:2009-10-09

    申请号:KR1020080101903

    申请日:2008-10-17

    CPC classification number: C12Q1/6886 C12Q2600/118 C12Q2600/158 C40B40/08

    Abstract: PURPOSE: A marker for diagnosing lung cancer susceptibility using HER-2 gene is provided to predict and screen high risk group of lung cancer, diagnose and treat lung cancer. CONSTITUTION: A marker for diagnosing lung cancer susceptibility comprises one or more polynucleotide selected from a group comprising: a polynucleotide having 1316th base of polynucleotide sequence number 1 (-3444th from translation initiator element of HER-2 gene) which C is substituted with T and comprising 100-500 serial DNA fragments, a polynucleotide having 2771th base which G is substituted with T and comprising 100-500 serial DNA fragments; and a polynucleotide having 32301th base which C is substituted with G and comprising 100-500 serial DNA fragments and its complementary polynucleotide.

    Abstract translation: 目的:提供使用HER-2基因诊断肺癌易感性的标志物,用于预测和筛选肺癌高危组,诊断和治疗肺癌。 构成:用于诊断肺癌易感性的标记物包含一种或多种选自以下的多核苷酸:包含多核苷酸序列号1316的碱基(HER-2基因的翻译起始元件为第3444位)的多核苷酸,C被T取代, 包含100-500个连续DNA片段,具有第2771个碱基的多核苷酸,其G被T取代并包含100-500个连续DNA片段; 和具有32位碱基的多核苷酸,其C被G取代并且包含100-500个连续DNA片段及其互补多核苷酸。

Patent Agency Ranking